Download this PDF file
Crossref Citations
1. Evaluation of an attenuated strain of Ehrlichia canis as a vaccine for canine monocytic ehrlichiosis
Nir Rudoler, Gad Baneth, Osnat Eyal, Michael van Straten, Shimon Harrus
Vaccine vol: 31 issue: 1 first page: 226 year: 2012
doi: 10.1016/j.vaccine.2012.10.003
2. Effect of GP19 Peptide Hyperimmune Antiserum on Activated Macrophage during Ehrlichia canis Infection in Canine Macrophage-like Cells
Boondarika Nambooppha, Amarin Rittipornlertrak, Anucha Muenthaisong, Pongpisid Koonyosying, Sahatchai Tangtrongsup, Saruda Tiwananthagorn, Yang-Tsung Chung, Nattawooti Sthitmatee
Animals vol: 11 issue: 8 first page: 2310 year: 2021
doi: 10.3390/ani11082310
3. Recombinant Ehrlichia canis GP19 Protein as a Promising Vaccine Prototype Providing a Protective Immune Response in a Mouse Model
Boondarika Nambooppha, Amarin Rittipornlertrak, Anucha Muenthaisong, Pongpisid Koonyosying, Paweena Chomjit, Kanokwan Sangkakam, Sahatchai Tangtrongsup, Saruda Tiwananthagorn, Nattawooti Sthitmatee
Veterinary Sciences vol: 9 issue: 8 first page: 386 year: 2022
doi: 10.3390/vetsci9080386
4. Ehrlichia canis Vaccine Development: Challenges and Advances
Bruna Samara Alves-Ribeiro, Raiany Borges Duarte, Zara Mariana de Assis-Silva, Ana Paula Carvalho Gomes, Yasodaja Assis Silva, Lizandra Fernandes-Silva, Alice Caroline da Silva Rocha, Iago de Sá Moraes, Klaus Casaro Saturnino, Dirceu Guilherme de Souza Ramos, Isis Indaiara Gonçalves Granjeiro Taques, Ísis Assis Braga
Veterinary Sciences vol: 11 issue: 12 first page: 624 year: 2024
doi: 10.3390/vetsci11120624
